Fresenius Kabi USA, LLC recalls Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, S
Recalled July 29, 2026 · FDA recall D-0729-2026 · Fresenius Kabi USA
Hazard
Presence of Particulate Matter: Hair was found in products · FDA Class II
Units
37,250 vials
Sold at
Nationwide within in the USA
Description
Presence of Particulate Matter: Hair was found in products
Product
Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03
Manufacturer(s)
Fresenius Kabi USA, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →